Rockwell Medical, Inc. (RMTI) stock
Close on Nov 11, 2026Market cap $28.54MP/E –Yield –
Rockwell Medical, Inc. saw revenue fall 4.0% to $72.58M over the twelve months to Sep 30, 2026. Free cash flow was $828.00K. At the latest close the market valued the company at $28.54M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $28.54M
- P/E ratio
- –
- Price to sales
- 0.41
- Price to book
- 0.81
- Dividend yield
- –
- Free cash flow yield
- 5.40%
Fundamentals
- Revenue
- $72.58M
- Net income
- -$5.66M
- EPS, diluted
- -$1.47
- Free cash flow
- $828.00K
- Book value per share
- $8.34
- Diluted shares
- 4M
Trading
- Next earnings
- Nov 11, 2026 (estimated, before the open)
- Previous close
- $7.31
- Open
- $7.30
- Day's range
- $7.02 – $7.55
- Volume
- 20,396
- Average volume (20 days)
- 27,554
- Beta (5 years)
- 1.80
- 52-week range
- $4.88 – $12.90
- RSI (14 days)
- 43.0
- Volatility (1 year)
- 69.6%
- Relative volume
- 0.74×
- WACC
- 12.9%
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | RMTI | S&P 500 | Difference | RMTI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -10.3% | -2.4% | −7.9 pts | ||
| 3 months | 0.0% | -1.2% | +1.2 pts | ||
| Year to date | -15.1% | +12.3% | −27.3 pts | ||
| 1 year | -32.6% | +12.4% | −45.0 pts | ||
| 3 years | -61.5% | +78.8% | −140.3 pts | -27.3% | +21.4% |
| 5 years | -88.1% | +75.2% | −163.2 pts | -34.6% | +11.9% |
| 10 years | -98.8% | +311.1% | −409.9 pts | -35.9% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Rockwell Medical filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- News
- Update
- Results
- Update
About Rockwell Medical
Pharmaceutical Preparations
Rockwell Medical, Inc. develops, manufactures, commercializes, and distributes hemodialysis concentrates and dialysate products for end-stage kidney disease treatment. The company produces liquid and dry formulations of citric and acetic acid concentrates, bulk and individual bicarbonate powders, single-use bicarbonate cartridges, and dedicated dry acid mixing systems. In addition, it supplies ancillary hemodialysis items such as cleaning agents, descalers, and water softener salt pellets. These medical products serve freestanding outpatient clinics, hospital-based centers, skilled nursing facilities, and home healthcare settings. Rockwell Medical provides its portfolio directly to dialysis service organizations and through healthcare distributors.
Company profile, executives and historyRockwell Medical stock: common questions
What is Rockwell Medical's stock price?
RMTI closed at $7.08 on Nov 11, 2026, down 3.15% on the day. Over the past 52 weeks it traded between $4.88 and $12.90.
What is Rockwell Medical's market cap?
Rockwell Medical was worth $28.54M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is RMTI's P/E ratio?
Rockwell Medical lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.47), so it has no meaningful P/E ratio.
How much revenue does Rockwell Medical make?
Rockwell Medical reported revenue of $72.58M for the twelve months to Sep 30, 2026, down 4.0% from a year earlier.
Does Rockwell Medical pay a dividend?
No. Rockwell Medical has not paid a cash dividend over the last twelve months.
When does Rockwell Medical report earnings next?
Rockwell Medical is expected to report Q3 FY2026 results on Nov 11, 2026, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has RMTI stock performed over the past year?
Including dividends, RMTI returned -32.6% over the past year, against +12.4% for the S&P 500.
Who are Rockwell Medical's competitors?
Companies most similar to Rockwell Medical by business, industry and size include DERM, AKBA, LXRX, ETON, FBIO.
See a number that looks wrong?